Lexaria Bioscience: Ingesting Versus Inhaling Could Save 60,000 Lives a Year
“Everybody knows that smoking is not healthy. Thus, our technology delivers drug molecules like cannabinoids or nicotine through ingesting means. Also …
Technology for healthier drug molecule delivery
“Everybody knows that smoking is not healthy. Thus, our technology delivers drug molecules like cannabinoids or nicotine through ingesting means. Also, the things that you swallow and that could be a pill, it could be a syrup, could be a cup of coffee. Therefore if we are able to help change the consumption habits of even 1 percent of the global marketplace who smoke we could save 60,000 lives a year.” – Chris Bunka, CEO of Lexaria Bioscience.
Lexaria Bioscience Corp. developed and out-licenses its technology named DehydraTECH™ that promotes -
- Healthier administration methods
- Lower overall dosing
- Higher effectiveness of ingestible drugs and other beneficial molecules.
This technology is protected by a robust suite of patents granted or pending worldwide. Thus is proven effective in multiple international studies and quantity of absorption of a range of molecules. DehydraTECH delivery technology offers a workable and healthier alternative. Basically in other delivery methods for substances such as inhalational delivery through smoking.
For more information on Lexaria Bioscience Corp. (NASDAQ: LEXX) please fill out the form below.
Latest Articles
.png)
Hot Companies
You might also like
.png)
CEO Clip - Coyote Copper: Could Arizona’s Copper Triangle Host Another Major Copper Discovery?
Coyote Copper is advancing a large-scale copper exploration project in Arizona’s “Copper Triangle”, strategically positioned near major copper deposits in one of the United States’ most established copper districts.
